Stock ORT B ORTOMA AB (PUBL)
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Ortoma AB (publ) NORDIC GROWTH MARKET

Equities

ORT B

SE0005676103

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2023-02-21 pm EST 		5-day change 1st Jan Change
5.76 SEK +1.41% Intraday chart for Ortoma AB (publ) +3.60% -22.16%
May. 23 Ortoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 20 Ortoma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • With an enterprise value anticipated at 3.09 times the sales for the current fiscal year, the company turns out to be overvalued.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
ORTOMA AB (PUBL) Stock Ortoma AB (publ)
-22.16% 30.91M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-1.55% 30.06B
C
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+37.51% 9.49B
C-
SECTRA AB Stock Sectra AB
+35.03% 4.43B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-40.15% 2.25B
C-
VERADIGM INC. Stock Veradigm Inc.
-6.58% 1.66B -
C+
OMNICELL, INC. Stock Omnicell, Inc.
-28.66% 1.23B
B
LUNIT INC. Stock Lunit Inc.
-41.27% 965M -
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-6.34% 826M
C
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-49.31% 715M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
  1. Stock Market
  2. Equities
  3. ORT B Stock
  4. ORT B Stock
  5. Ratings Ortoma AB (publ)